I Mab : Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 - Form 6-K : vimarsana.com

I Mab : Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 - Form 6-K

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022




·


... | May 1, 2023

Related Keywords

Shanghai , China , Maryland , United States , Lishui , Zhejiang , Hong Kong , Gaithersburg , Wuhan , Hubei , Beijing , South Korea , San Diego , California , Henan , Hangzhou , Guangzhou , Guangdong , Wuxi , Jiangsu , American , Chinese , Andrew Zhu , Jingwu Zang , Genexine Neoimmunetech , Richard Yeh , Gigi Feng , Corporate Development , Twitter , European Society For Medical Oncology , Us Public Company Accounting Oversight Board , Morgan Stanley Capital International , Women Leadership Council , Linkedin , Tracon Pharmaceuticals , Exchange Rate Information , Holding Foreign Companies Accountable , American Society Of Clinical Oncology , Company Nasdaq , Holding Foreign Companies Accountable Act , Nasdaq , Company Responses To Recent , Company American Depositary , Henan Charity , Research Development Expenses , Exchange Commission , Pipeline Development , I Mab Provides Business , Corporate Updates , Reports Financial Results , Year Ended December , West Tower , Pipeline Development Highlights , Medical Oncology , Drug Evaluation , Clinical Oncology , Wuxi Diagnostics , Drug Designation , Recent Challenges , Cash Burn Rate , Potential Challenges , Company Accounting Oversight Board , Commission Identified Issuer , Strong Commitment , Henan Charity General Federation , Henan Province , Leadership Council , Asia Pacific Diversity , Inclusivity Best Practice Guide , American Depositary Shares , I Mab Hangzhou , Securities Litigation Reform Act , Federal Reserve , Operating Officer , Chief Financial Officer , Comprehensive Income , Ended December , I Mab Stock Exchange , Ews , Nformation , Ress Release , Rovides , Usiness , Nd , Orporate , Pdates , Eports , Inancial , Esults , Or , He , Ear , Nded , Ecember Imab Us44975p1030 ,

© 2024 Vimarsana